drugset / Trial / NCT06906731
A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, multi-center, multiple doses Phase I/II study to evaluate the safety, tolerability ,pharmacokinetics and efficacy of SHR-9803 for injection in subjects with advanced solid tumors.
Timeline
- Start
- 2025-04
- Primary completion
- 2027-06
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR-9803 | Unknown | — | — |